Vietnam Acute Pain Market Growth Rate
According to 6Wresearch internal databases and industry insights, the Vietnam Acute Pain Market is projected to grow at a compound annual growth rate (CAGR) of 8.1% during the forecast period 2026–2032.
Vietnam Acute Pain Market Year-wise Growth Rate and Key Drivers (2022-2032)
This graph illustrates the annual growth rates of the Vietnam Acute Pain Market from 2022 to 2032, demonstrating a rise in growth trajectory and projected market expansion over the forecast period.
The following table summarizes the historical and forecasted growth rates of the Vietnam Acute Pain Market, along with the rationale behind each year’s performance.
| Year | Estimated Growth (%) | Market Rationale |
| 2022 | 5.5% | Improved healthcare services and pushing the demand for pain management treatments, especially after the pandemic disruptions. |
| 2023 | 6.2% | Awareness of pain relief medicines and hospital treatment needs have increased and support the growth of market. |
| 2024 | 6.7% | Expansion of healthcare facilities and increasing use of prescription pain management therapies drive demand. |
| 2025 | 7.2% | Increase in number of elderly people and chronic pain patients increases the demand for acute pain medications. |
| 2026 | 7.9% | Improved access to healthcare services and advanced pain treatment options support market expansion. |
| 2027 | 6.4% | Favourable pharmaceutical supply chain and increased availability of pain relief medications will help the market grow. |
| 2028 | 6.8% | Growth of private hospitals and a greater number of patients' visits to support demand for acute pain treatment. |
| 2029 | 7.1% | Increased use of advanced analgesics and healthcare infrastructure will boost market growth. |
| 2030 | 7.4% | Increase in healthcare expenditures and use of innovative pain therapies will drive the long-term growth. |
| 2031 | 7.8% | Improved distribution of pharmaceutical products facilitates access to pain management products. |
| 2032 | 8.1% | Strong healthcare investment and growing demand for effective pain treatment support market expansion. |
Topics Covered in the Vietnam Acute Pain Market Report
The Vietnam Acute Pain Market report covers by drug Class, by application, by route of administration, by end User. The report provides a detailed analysis of ongoing trends in pharmaceutical outsourcing, generic medicine production and advanced drug manufacturing capabilities, along with key growth drivers and opportunities that will help stakeholders align strategies with current and future market dynamics.
Vietnam Acute Pain Market Highlights
| Report Name | Vietnam Acute Pain Market |
| Forecast period | 2026-2032 |
| CAGR | 8.1% |
| Growing Sector | Healthcare |
Vietnam Acute Pain Market Synopsis
The Vietnam Acute Pain Market is witnessing a steady growth, with hospitals reporting higher surgical loads and trauma admissions across both public and private systems. Orthopedic procedures, caesarean deliveries, dental surgeries, and emergency trauma cases remain the biggest contributors to demand, and post-operative pain care has slowly become a fixed part of hospital protocol rather than an afterthought. Institutions such as Cho Ray and Bach Mai are formalizing dedicated pain services, and private chains are following suit with their own surgical pain teams.
Evaluation of Growth Drivers in Vietnam Acute Pain Market (2026–2032)
Below are some major drivers and their influence on the market dynamics:
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Rising paediatric ear infection cases | Antibiotics segment | Higher incidence of AOM is increasing demand for antibiotic therapies. |
| Expanding healthcare infrastructure | Hospitals | Improved access to ENT specialists and treatment services supports market growth. |
| Growing awareness of early diagnosis | Oral formulations | Early treatment is increasing the use of oral antibiotics and pain relief medicines. |
| Increasing availability of pediatric-friendly medicines | Oral formulation segment | Child-friendly formulations are improving treatment adherence and patient outcomes. |
| Expansion of retail and online pharmacies | Retail & online pharmacy segment | Better medicine availability and convenient access are supporting treatment uptake. |
The Vietnam Acute Pain Market is expected to rise at a CAGR of 8.1% during the forecast period 2026–2032, supported by increasing healthcare utilization, rising surgical procedures, growing trauma cases, and improving access to pain management therapies. The expansion of urban areas, with Vietnam’s urbanization rate reaching over 40% of the total population, is contributing to higher demand for advanced healthcare services, including emergency care, postoperative pain management, and chronic pain interventions. The growing number of surgical procedures is another important factor driving demand for acute pain management solutions, including analgesics, regional anesthesia products, and pain control devices. Additionally, the country’s health insurance coverage has expanded significantly, reaching approximately 90% of the population, improving access to medical treatments and pain management services.
Evaluation of Restraints in Vietnam Acute Pain Market
Below are some major restraints and their impacts on the market dynamics:
| Restraints | Primary Segment Affected | What This Means (Evidence) |
| Rising prevalence of pain-related conditions and chronic pain disorders | Analgesics and pain management segment | Increases the demand for effective pain therapies while creating challenges in long-term pain management and medication safety. |
| Limited access to specialized pain management services in rural areas | Rural healthcare services | Delays accurate pain assessment, diagnosis, and access to advanced treatment options in underserved regions of Vietnam. |
| High cost of advanced pain therapies and innovative treatments | Treatment affordability | Patients with low budget often rely on conventional analgesics and over-the-counter pain medications. |
| Self-medication and inappropriate use of analgesics | Patient outcomes | Risk of medication misuse increase, adverse effects, and inadequate pain control among patients. |
| Stringent regulatory approval process for new pain management drugs | New drug launches | Delays the introduction and availability of innovative acute pain therapies in the Vietnamese market. |
Vietnam Acute Pain Market Challenges
Some major challenges are affecting the Vietnam Acute Pain Market Growth, such as reliance on imported analgesics and raw pharmaceutical materials. Domestic production of controlled substances hasn't developed much, so most hospitals still depend on multinational suppliers for injectable and branded pain drugs. Due to these issues, shipping delays and price fluctuations can throw off pharmacy stock levels right when demand peaks. Smaller regional hospitals and distributors tend to struggle here more than their urban counterparts, and over time this disparity has widened the gap between what a well-funded city hospital can stock versus a provincial one.
Vietnam Acute Pain Market Trends
Here are some emerging trends in the Vietnam Acute Pain Market, including:
- Rising day-surgery volumes: More procedures are moving to same-day and outpatient settings, favouring faster-acting analgesics with shorter recovery windows.
- Shift toward multimodal analgesia: Doctors are increasingly combining opioid and non-opioid drugs to manage pain while keeping dependency risk in check.
- Growing focus on pain training: Specialist bodies are running workshops to try and introduce some consistency to acute pain protocols across tiers of hospitals.
- Private sector stepping up: Private hospital groups are setting up standalone acute pain units instead of folding them into general surgical care.
Investment Opportunities in the Vietnam Acute Pain Industry
Some promising opportunities in the Vietnam Acute Pain Market, include the following:
- Non-opioid drug development: Firms working on safer alternatives to opioids have an opening to win over cautious prescribers early.
- Clinical training partnerships: Backing hospital training programs helps build lasting relationships with the clinicians writing prescriptions.
- Distribution and cold-chain investment: Strengthening supply routes to provincial hospitals could close existing gaps in injectable analgesic availability.
Top Players in Vietnam Acute Pain Market
A comprehensive list of major companies operating in the Vietnam Acute Pain Market is provided below:
1. Pfizer Vietnam
| Company Name | Pfizer Vietnam |
|---|---|
| Established Year | 2010 (Subsidiary), incorporated in 2019 |
| Headquarters | Ho Chi Minh City, Vietnam |
| Official Website | Click Here |
Pfizer operates as the local subsidiary of Pfizer, providing innovative prescription medicines, vaccines, and healthcare solutions while supporting disease prevention, patient care, and medical research across Vietnam.
2. Sanofi Vietnam
| Company Name | Sanofi Vietnam |
|---|---|
| Established Year | 2008 |
| Headquarters | Ho Chi Minh City, Vietnam |
| Official Website | Click Here |
Sanofi Vietnam manufactures and markets prescription medicines, vaccines, and consumer healthcare products, serving hospitals, pharmacies, and healthcare providers throughout Vietnam.
3. GSK Vietnam (GlaxoSmithKline Vietnam)
| Company Name | GSK Vietnam (GlaxoSmithKline Vietnam) |
|---|---|
| Established Year | 1994 (operations in Vietnam) |
| Headquarters | Ho Chi Minh City, Vietnam |
| Official Website | Click Here |
GSK in Vietnam provides prescription medicines, vaccines, and consumer healthcare products, supporting preventive healthcare and pharmaceutical innovation across the Vietnamese healthcare sector.
4. DHG Pharmaceutical JSC (DHG Pharma)
| Company Name | DHG Pharmaceutical JSC (DHG Pharma) |
|---|---|
| Established Year | 1994 |
| Headquarters | Can Tho City, Vietnam |
| Official Website | Click Here |
DHG Pharma is one of Vietnam's leading pharmaceutical manufacturers, producing prescription medicines, over-the-counter drugs, dietary supplements, and healthcare products for domestic and international markets.
5. Traphaco JSC
| Company Name | Traphaco JSC |
|---|---|
| Established Year | 1972 |
| Headquarters | Hanoi, Vietnam |
| Official Website | Click Here |
Traphaco is a leading Vietnamese pharmaceutical company specializing in the research, manufacturing, and distribution of herbal medicines, prescription drugs, and healthcare products, with a strong nationwide distribution network.
Government Regulations Being implemented in the Vietnam Acute Pain Market
The Vietnam Acute Pain Market is influenced by healthcare regulations focused on ensuring the safe use, quality, and accessibility of pain management medicines and medical products. The Ministry of Health (MoH) of Vietnam, through the Drug Administration of Vietnam (DAV), regulates the approval, distribution, storage, and monitoring of analgesic medications, including controlled substances such as opioid-based pain relievers.
Under Vietnam’s pharmaceutical management framework, hospitals and pharmacies handling controlled medicines are required to maintain detailed records related to procurement, storage, dispensing, and usage. For example, opioid analgesics such as morphine and fentanyl used in surgical departments, intensive care units, and oncology-related pain management must follow strict prescription and inventory control procedures. These measures help improve medication safety and strengthen monitoring across healthcare facilities.
Future Insights into Vietnam Acute Pain Market
The Vietnam Acute Pain Market is projected to experience considerable growth in the upcoming years due to the increasing number of surgical procedures, improvements in healthcare infrastructure, growing insurance coverage, and rising awareness about modern pain management techniques. Vietnam’s healthcare industry is consistently growing with overall healthcare spending rising due to economic progress and an increasing demand for more advanced medical care.
The aging population of the country is expected to further impact the future demand for pain management solutions. In 2023, approximately 14% of the population in Vietnam was 60 years old and above and the number is expected to rise in the coming decades, resulting in an increase in the incidence of musculoskeletal disorders, post-operative pain and age-related conditions that need effective pain control.
Market Segmentation Analysis
This report provides a detailed analysis of the segments along with their leading categories.
By Drug Class – Analgesics Segment Dominates the Market
According to Bhawna Singh, Assistant Manager, 6Wresearch, Analgesics accounted for an estimated 60.4% of Vietnam Acute Pain Market Share, making it the leading drug class due to extensive usage in surgical pain, trauma pain, and general acute pain management. Meanwhile, Anticonvulsants segment is expected to grow at an estimated CAGR of around 7.7% during 2026–2032, due to increasing use in neuropathic pain management and adoption of multimodal pain treatment approaches.
By Route of Administration – Oral Segment Captures the Major Share
The oral route segment leads the Vietnam acute pain market, accounting for 56% market share due to ease of administration, affordability and widespread availability of pain medications. In contrast, Parenteral segment is set to register an estimated CAGR of around 7.9% during 2026–2032, owing to increasing use in emergency care, surgical procedures, and hospital treatment settings requiring faster pain relief.
By End User – Hospitals Lead the Market
The hospital segment dominates the market with major share, capturing 46.5% of the Vietnam acute pain market due to higher surgical volumes, emergency care demand and availability of specialized pain management services. In contrast, Home Care Settings segment is expected to grow at an estimated CAGR of around 8.3% during 2026–2032, driven by increasing demand for outpatient pain management and ageing population needs.
Note: Market size estimations and growth projections shared in this report are based on 6Wresearch’s proprietary forecasting methodology, with the aid of the latest available industry data, government publications and primary research inputs.
Key Attractiveness of the Report:
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year: 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- Vietnam Acute Pain Market Outlook
- Market Size of Vietnam Acute Pain Market, 2025
- Forecast of Vietnam Acute Pain Market, 2032
- Historical Data and Forecast of Vietnam Acute Pain Revenues & Volume for the Period 2022-2032
- Vietnam Acute Pain Market Trend Evolution
- Vietnam Acute Pain Market Drivers and Challenges
- Vietnam Acute Pain Price Trends
- Vietnam Acute Pain Porter's Five Forces
- Vietnam Acute Pain Industry Life Cycle
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Drug Class for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By NSAIDs for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Anesthetics for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Anticonvulsants for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Anti-migraine for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Agents for the Period 2022 - 2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Antidepressants for the Period 2022 - 2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Analgesics for the Period 2022 - 2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Application for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Surgical Pain for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Trauma Pain for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Cancer Pain for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Arthritis Pain for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Migraine for the Period 2022 - 2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Route of Administration for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Oral for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Parenteral for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Transdermal for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Others for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By End User for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Hospitals for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Clinics for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Ambulatory Surgical Centres for the Period 2022-2032
- Historical Data and Forecast of Vietnam Acute Pain Market Revenues & Volume By Home Care Settings for the Period 2022-2032
- Vietnam Acute Pain Import Export Trade Statistics
- Market Opportunity Assessment By Drug Class
- Market Opportunity Assessment By Application
- Market Opportunity Assessment By Route of Administration
- Market Opportunity Assessment By End User
- Vietnam Acute Pain Top Companies Market Share
- Vietnam Acute Pain Competitive Benchmarking By Technical and Operational Parameters
- Vietnam Acute Pain Company Profiles
- Vietnam Acute Pain Key Strategic Recommendations
Market Covered
The report offers an extensive study of the following market segments:
By Drug Class
- NSAIDs
- Anesthetics
- Anticonvulsants
- Anti-migraine Agents
- Antidepressants
- Analgesics
By Application
- Surgical Pain
- Trauma Pain
- Cancer Pain
- Arthritis Pain
- Migraine
By Route of Administration
- Oral
- Parenteral
- Transdermal
- Others
By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centres
- Home Care Settings
